$DORM
Dorman Products, Inc.

2022 Q3 Form 10-Q Financial Statement

#000156459022026318 Filed on July 25, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $413.5M $417.4M $401.6M
YoY Change 18.67% 34.38% 39.43%
Cost Of Revenue $281.6M $275.9M $268.3M
YoY Change 21.59% 37.6% 46.23%
Gross Profit $131.9M $141.5M $133.2M
YoY Change 12.89% 28.51% 27.5%
Gross Profit Margin 31.9% 33.9% 33.18%
Selling, General & Admin $89.81M $92.06M $86.53M
YoY Change 23.6% 32.43% 37.56%
% of Gross Profit 68.09% 65.05% 64.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.53M $9.857M $9.743M
YoY Change 42.69% 3.21% 33.47%
% of Gross Profit 8.74% 6.96% 7.31%
Operating Expenses $89.81M $92.06M $86.53M
YoY Change 23.6% 32.43% 37.56%
Operating Profit $42.10M $49.47M $46.71M
YoY Change -4.74% 21.82% 12.29%
Interest Expense $2.344M $1.565M $1.231M
YoY Change -419.78% 2384.13% 917.36%
% of Operating Profit 5.57% 3.16% 2.64%
Other Income/Expense, Net -$65.00K $111.0K $84.00K
YoY Change -168.42% -27.45% -1.18%
Pretax Income $39.69M $48.01M $45.57M
YoY Change -8.87% 17.97% 9.49%
Income Tax $9.087M $10.11M $10.36M
% Of Pretax Income 22.9% 21.05% 22.73%
Net Earnings $30.60M $37.91M $35.21M
YoY Change -7.56% 19.88% 7.57%
Net Earnings / Revenue 7.4% 9.08% 8.77%
Basic Earnings Per Share $0.97 $1.21 $1.12
Diluted Earnings Per Share $0.97 $1.20 $1.11
COMMON SHARES
Basic Shares Outstanding 31.43M 31.42M 31.50M
Diluted Shares Outstanding 31.55M 31.54M 31.60M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.44M $51.97M $53.43M
YoY Change -38.12% -66.59% -67.93%
Cash & Equivalents $35.44M $51.97M $53.43M
Short-Term Investments
Other Short-Term Assets $30.46M $26.97M $13.51M
YoY Change 76.08% 67.81% 37.83%
Inventory $677.9M $634.8M $565.2M
Prepaid Expenses
Receivables $433.2M $417.4M $456.1M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.177B $1.131B $1.088B
YoY Change 16.18% 16.05% 12.58%
LONG-TERM ASSETS
Property, Plant & Equipment $122.1M $117.9M $116.2M
YoY Change 4.98% -6.74% -10.8%
Goodwill $195.7M $197.2M $198.1M
YoY Change -2.15%
Intangibles $169.0M $172.7M $176.1M
YoY Change -7.54%
Long-Term Investments
YoY Change
Other Assets $44.87M $45.78M $47.53M
YoY Change -2.14% -14.94% -8.43%
Total Long-Term Assets $624.2M $630.1M $636.1M
YoY Change 3.56% 113.69% 113.67%
TOTAL ASSETS
Total Short-Term Assets $1.177B $1.131B $1.088B
Total Long-Term Assets $624.2M $630.1M $636.1M
Total Assets $1.801B $1.761B $1.724B
YoY Change 11.47% 38.73% 36.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $199.2M $203.5M $165.8M
YoY Change 32.85% 60.88% 39.95%
Accrued Expenses $245.3M $227.5M $257.4M
YoY Change 9.78% 10.41% 18.68%
Deferred Revenue
YoY Change
Short-Term Debt $229.4M $229.4M $229.4M
YoY Change -8.02%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $673.9M $660.3M $652.6M
YoY Change 8.21% 98.58% 94.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.159M $5.117M $94.33M
YoY Change 9.63% -87.34% 128.4%
Total Long-Term Liabilities $5.159M $5.117M $94.33M
YoY Change 9.63% -87.34% 128.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $673.9M $660.3M $652.6M
Total Long-Term Liabilities $5.159M $5.117M $94.33M
Total Liabilities $679.0M $665.5M $764.9M
YoY Change 8.22% 76.75% 101.03%
SHAREHOLDERS EQUITY
Retained Earnings $939.2M $910.2M
YoY Change 13.04%
Common Stock $85.69M $82.51M
YoY Change 16.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.021B $991.0M $959.4M
YoY Change
Total Liabilities & Shareholders Equity $1.801B $1.761B $1.724B
YoY Change 11.47% 38.73% 36.39%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $30.60M $37.91M $35.21M
YoY Change -7.56% 19.88% 7.57%
Depreciation, Depletion And Amortization $11.53M $9.857M $9.743M
YoY Change 42.69% 3.21% 33.47%
Cash From Operating Activities -$8.042M $14.17M $23.21M
YoY Change -120.88% -21.65% 10.44%
INVESTING ACTIVITIES
Capital Expenditures -$7.680M -$8.853M $7.247M
YoY Change 49.97% 123.96% 16.76%
Acquisitions -$595.0K
YoY Change
Other Investing Activities $0.00 $0.00 $595.0K
YoY Change -100.0%
Cash From Investing Activities -$7.680M -$8.853M -$6.652M
YoY Change -97.81% 123.96% 7.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities -723.0K -6.724M -21.96M
YoY Change -100.34% -73.29% 480.11%
NET CHANGE
Cash From Operating Activities -8.042M 14.17M 23.21M
Cash From Investing Activities -7.680M -8.853M -6.652M
Cash From Financing Activities -723.0K -6.724M -21.96M
Net Change In Cash -16.44M -1.405M -5.355M
YoY Change -83.26% -87.27% -148.56%
FREE CASH FLOW
Cash From Operating Activities -$8.042M $14.17M $23.21M
Capital Expenditures -$7.680M -$8.853M $7.247M
Free Cash Flow -$362.0K $23.03M $15.97M
YoY Change -100.83% 4.47% 7.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58782000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
51966000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
155539000
us-gaap Interest Paid Net
InterestPaidNet
2285000
us-gaap Interest Paid Net
InterestPaidNet
140000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
36700000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26436000
CY2021Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
5948000
CY2022Q2 us-gaap Inventory Net
InventoryNet
634774000
CY2021Q4 us-gaap Inventory Net
InventoryNet
531988000
dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P365D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M18D
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3M18D
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
37905000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
31618000
us-gaap Net Income Loss
NetIncomeLoss
73112000
us-gaap Net Income Loss
NetIncomeLoss
64348000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
12746000
CY2022Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
236354000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31424000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
155576000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-146000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1999000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
37905000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
883811000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
420000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2380000
CY2021Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
27275000
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2493000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-462000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
31618000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
932736000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
957000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4270000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
18195000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
377000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1997000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-303000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
990957000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
853559000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
736000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4491000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
31249000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2493000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1393000
us-gaap Net Income Loss
NetIncomeLoss
64348000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
892985000
us-gaap Profit Loss
ProfitLoss
64348000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
16850000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
31000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-213000
us-gaap Share Based Compensation
ShareBasedCompensation
4491000
dorm Proceeds From Purchase Price Adjustment
ProceedsFromPurchasePriceAdjustment
595000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16100000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15505000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
10000000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
894000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
736000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
18195000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
30848000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-1386000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
1141000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28687000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28971000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-10000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6816000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-37000
CY2022Q2 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
262900000
CY2021Q2 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
223800000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
538100000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
433700000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
178809000
CY2022Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
15997000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31942000
CY2021Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
225879000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
373537000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
287415000
CY2022Q2 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
8886000
CY2021Q4 us-gaap Goodwill
Goodwill
197332000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-167000
CY2022Q2 us-gaap Goodwill
Goodwill
197165000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
194807000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22149000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
172658000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
194807000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15998000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3100000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
95226
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31461000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31995000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
100.79
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
51027
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
111000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
147000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
3600000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417419000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
310635000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
818998000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
598647000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417419000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
310635000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
206677
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
85.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
83.67
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
40002
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
83.51
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
210874
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
93.69
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
400000
CY2021Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
300000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
800000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
600000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
233396
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
77.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
78574
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
97.16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11236
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
77.45
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
30972
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
71.73
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
269762
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2699534000
dorm Lease Effective Date
LeaseEffectiveDate
2018-01-01
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
84.20
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5532808000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
94126
CY2022Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
76.03
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
107000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
141000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31535000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32089000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31568000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32136000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.21
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.00
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1300000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
2300000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
892985000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
818998000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
598647000
us-gaap Net Income Loss
NetIncomeLoss
73112000
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
7278000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
990957000

Files In Submission

Name View Source Status
0001564590-22-026318-index-headers.html Edgar Link pending
0001564590-22-026318-index.html Edgar Link pending
0001564590-22-026318.txt Edgar Link pending
0001564590-22-026318-xbrl.zip Edgar Link pending
dorm-10q_20220625.htm Edgar Link pending
dorm-10q_20220625_htm.xml Edgar Link completed
dorm-20220625.xsd Edgar Link pending
dorm-20220625_cal.xml Edgar Link unprocessable
dorm-20220625_def.xml Edgar Link unprocessable
dorm-20220625_lab.xml Edgar Link unprocessable
dorm-20220625_pre.xml Edgar Link unprocessable
dorm-ex311_7.htm Edgar Link pending
dorm-ex312_6.htm Edgar Link pending
dorm-ex32_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gkdcvhvgl200000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending